Vacunas para la deshabituación tabáquica

Garrido, P.; Prat, A.; Crespo, Inma; Valverde, Araceli; Salvador, Escalante Batista

doi:10.1016/s1576-9887(12)70058-4

Cited by 1 publication

(2 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A vaccine, however, would need to be compatible and complementary with other smoking-cessation treatments. It would be indicated for the following groups of subjects: (a) heavy smokers who have made multiple unsuccessful attempts to quit using different methods; (b) patients who are highly motivated to quit; and (c) patients who have positive attitudes toward vaccines 20 . Modifications designed to improve serum antibody affinity are being tested and may improve the performance of future clinical candidate vaccines [21][22][23] .…”

Section: Vaccinesmentioning

confidence: 99%

See 1 more Smart Citation

Smoking Cessation Treatments: Current Psychological and Pharmacological Options

García-Gómez¹,

Hernández-Pérez²,

Noé-Díaz³

et al. 2019

RIC

View full text Add to dashboard Cite

Background: Smoking is considered an epidemic, indeed, one of the most important public health problems worldwide. It is also the most significant preventable cause of death, of a high number of premature deaths, and avoidable chronic diseases. It is considered an enormous economic burden for the world. Objective: To provide an overview of smoking-cessation treatments, including pharmacological and psychological options, and to gather current scientific evidence available on them. Methods: Research included reviewing publications from 2007-2018 in four databases using algorithms related to bupropion, varenicline, nicotine replacement therapy, smoking cessation, psychological treatment, motivational interview, cognitive-behavioral therapy and clinical guidelines for smoking treatment. Meta-analyses or systematic reviews and randomized or quasirandomized trials were selected. We also included clinical guidelines for smoking treatment from Mexico and other countries. Results: After refining the search, 37 articles met the criteria and were included in the review. The results were grouped by type of intervention. Conclusions: It is necessary to conduct research on combinations of both kinds of treatment with an integral, multidisciplinary vision. Current standard for smoking cessation is a combined psychological and pharmacological treatment.

show abstract

Section: Vaccinesmentioning

confidence: 99%

“…Zhao et al designed a series of nanovaccines, and their studies with mice showed that certain types of NPs exhibited the greatest ability to block nicotine from entering the brain 24 . Unfortunately, the assays conducted to date have revealed drawbacks that prevent these systems from achieving higher cessation rates than a placebo 20 .…”

Section: Vaccinesmentioning

confidence: 99%